P4 Precision Medicine Accelerator

Excijting Announcement! We are thrilled to announce that we are a founding partner of the London Institute for Healthcare Engineering (LIHE) Breakfast, a brand new event series bringing together key players in the digital health and data-driven ecosystem. This first-of-its-kind event will host NHS CIOs, CCIOs, NHS Digital Leaders, health-tech CEOs, investors, industry, policymakers, and other forward-thinking individuals from across the healthcare landscape for a day designed to foster the design of key strategies, solutions collaboration and innovation within our healthcare ecosystem. 💡 Event Details: 📍 Location: Hosted in partnership with, and located at the London Institute for Healthcare Engineering (LIHE), part of King’s College London. LIHE is the national asset for MedTech and SaMD, bringing together all the elements necessary for commercial and clinical translation under one roof. 🗓️ Date: 27th November 2024, will mark the date of the breakfast launch. If you're interested in joining us on the day, or exploring the opportunity to become a partner (limited spots available!), please register via the waitlist click the link below. https://lnkd.in/dZ6ba7Zi Nathan McNally Hassan Chaudhury HonFAPM Vita Healthcare Solutions @naomi amzi Meet Health Events London Institute for Healthcare Engineering #LIHEBreakfast

It was great to host the Beijing Ministry of Science and Technology after their visit to the Cambridge Biomedical Campus on how we are supporting our companies on their global expansion and the discussion around the benefit, barriers and opportunities in the China and Asia market with Nathan McNally and P4 Precision Medicine Accelerator Cheif Science Officer Ross Cagan and Professor of Personlised Medicine at University of Glasgow. P4 Alumni company Vivan Therapeutics and CEO Laura Towart on their recent progress and first steps entering the China market. Key points: 1. The market is complex but done right offers great new opportunities. 2. Universities and hospitals are open to collaborate to bring new technologies to market and that deliver improved healthcare in China offering great opportunities to scale. 3. Accessing China has opened up new discussions with the US, Asia and other territories. International Technology Transfer Network (ITTN) @Globaltech IP Department for Business and Trade

It’s exciting to announce that with all the work we’ve done at P4 Precision Medicine Accelerator over the years and with our portfolio scaling across the world that our Founder and CEO Nathan McNally has been nominated for the Forttuna Global Excellence Awards.

🚀 Exciting Opportunity Alert! 🚀 Attention to all UK-based MedTech innovators! Are you seeking to advance your revolutionary medical technology to the next stage? The MedTech Venture Builder (MVB) - a revolutionary 12-month programme that aims to boost your journey from concept to investment-ready venture! Led by the powerhouse collaboration of King's College London, Queen Mary University of London, City, University of London, and St George's, University of London MVB offers unparalleled support and expertise to propel your innovation forward. You can expect: ✅ Strategic milestone development ✅ Regulatory guidance ✅ Access to Quality Management System ✅ Investor engagement opportunities ✅ Ongoing post-programme support Plus, selected ventures receive £20,000 grant funding and space at London Institute for Healthcare Engineering Don't miss out on this unique opportunity to transform your MedTech vision into reality. Apply now (tiny.cc/j5soxz) and join us on the journey of innovation and impact! Applications close on May 21st, so act fast! #MedTech #Innovation #VentureBuilder #Healthcare #UKTech 🚀💡 Nathan McNally

Are you a scaling growing company looking to explore new markets? P4's mission to is to break down the barrier for precision medicine companies to scale and one barrier we have seen with our alumni and experience over the years is showing global applicability and entering new markets where understanding and early interaction/conversations are key. P4 is continuing to build the ecosystem globally and if you are interested in exploring new markets, visiting and meeting potential partners physically and gaining traction and validation, then we welcome you signing up your interest below. https://lnkd.in/ecbSQxcG P4 Precision Medicine Accelerator @globaltechIP Department for Business and Trade

Happy International Women's Day. Firstly to celebrate our great team, founders and great women's health innovations we have worked with and supported over the years and the ecosystem that has supported them across the journey. Jane Osborne-Buglear Julie Devonshire OBE Sally Bennett MBChB, CertIoD Neelam Patel Katerina Sanchez-Schilling Dina Molnar Lorraine Brown Loraine D. Cansu Deniz Bayrak Pilar Fernandez Hermida Brodie T. Georgina Rizik, MBA Rebecca Brown Laurel Ye Narges Amini Marija Butkovic Priya Oberoi Jen Estherby Uzma Choudry, Ph.D Ala Alenazi Riam Kanso - As well as all the other great women leaders, advisors and mentors. According to a Department of health and social care women want the health system to focus on: - Gynaecological conditions (63%) - Fertility, pregnancy, pregnancy loss and postnatal support (55%) - Menopause (48%) - Menstrual health (47%) - Mental health (39%) #internationalwomensday #womensday2024 #iwd2024

Precisio Biotix Therapeutics Acquires (P41) P4 2019 Alumni CC Bio. P4 Precision Medicine Accelerator Nathan McNally and the team are delighted for Matthew Cummings David Corcoran and the CC Bio team for what they have achieved.

Thank you Manish! P4 continues to support our companies across their journey as you open up for your series A it’s a pleasure setting up meetings for further funding rounds.

🎉 Congratulations to GlycanAge on securing €3.9 million in seed funding! 🚀 Thrilled to see the success of GlycanAge, a biotech startup pioneering personalised preventative healthcare through glycan biomarkers. As part of our P4SY accelerator programme where we ran a regional focused P4 programme to foster innovation and adoption in the South Yorkshire region, we've witnessed firsthand their dedication and innovation. Under the visionary leadership of CEO Nikolina Lauc and Chief Scientific Officer Dr. Gordan Lauc, GlycanAge is revolutionising healthcare with cutting-edge technology and scientific expertise. This funding milestone is a testament to their hard work and commitment to advancing glycomics and precision medicine. Excited to continue supporting GlycanAge on their journey to redefine healthcare. Here's to a future where healthcare is proactive, personalised, and accessible to all! https://lnkd.in/eBz8X-Hp 🌟 #HealthcareInnovation #PreventativeHealthcare #GlycanAge #SeedFundingSuccess 🌱💼

P4 Precision Medicine Accelerator has over 80+ mentors in the ecosystem plus over 500 organisations and 200 alumni that are on the same journey to pass on their experience. The strength of P4 is the network that is ever expanding. To gain support for your start up apply for 2024. Apply Now https://lnkd.in/g9gErAz